Cargando…
Modeling Approaches to Reimagine Stability (MARS) for Enabling Earlier Access to Critical Drugs for Patients with Unmet Medical Needs
FDA’s experience to date has shown that completion of stability data requirements is one of the most observed challenges for applicants of New Drug Applications (NDAs) with an expedited review designation. Since NDAs submitted under these expedited pathways often have limited available real-time sta...
Autores principales: | Furness, M. Scott, Cai, Hong, Chandramouli, Sithamalli, Chelliah, Mariappan, Chen, Xiao Hong, Ghosh, Debasis, Liu, Shaobo, McLamore, Sherita, Randad, Ramnarayan, Shen, Meiyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838275/ https://www.ncbi.nlm.nih.gov/pubmed/36631718 http://dx.doi.org/10.1208/s12249-022-02498-0 |
Ejemplares similares
-
Plant science decadal vision 2020–2030: Reimagining the potential of plants for a healthy and sustainable future
por: Henkhaus, Natalie, et al.
Publicado: (2020) -
Best Practices to Maximize the Use and Reuse of Quantitative and Systems Pharmacology Models: Recommendations From the United Kingdom Quantitative and Systems Pharmacology Network
por: Cucurull‐Sanchez, Lourdes, et al.
Publicado: (2019) -
First plant cell atlas workshop report
por: Rice, Selena, et al.
Publicado: (2020) -
Passive Transdermal Systems Whitepaper Incorporating Current Chemistry, Manufacturing and Controls (CMC) Development Principles
por: Van Buskirk, Glenn A., et al.
Publicado: (2012) -
Physiologically‐Based Pharmacokinetic Modeling in Renal and Hepatic Impairment Populations: A Pharmaceutical Industry Perspective
por: Heimbach, Tycho, et al.
Publicado: (2020)